Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study

Eur J Dermatol. 2013 Jan-Feb;23(1):94-8. doi: 10.1684/ejd.2012.1906.

Abstract

Bullous pemphigoid (BP) has been reported to be associated with significant morbidities and a considerable mortality rate. We retrospectively studied 94 patients with BP in a Chinese tertiary medical center between 2005 and 2010 to evaluate the treatment of BP and prognostic factors for the mortality of BP. Cerebrovascular diseases (42.55%) and hypertension (39.36%) were the most common pre-existing conditions. Cardiopathy, diabetes and psoriasis pre-existed in 24.47%, 22.34% and 5.32%, respectively. Eighty of all 94 patients were treated by systemic corticosteroid at prednisone 0.3 mg/kg to 1.5 mg/kg daily. Patients were followed up for a minimum of 1 year or until the time of death. The mean duration of follow-up was 32 months. Kaplan-Meier analysis showed a 1-year survival probability of 76.6% (standard error 4.4%), with a 95% confidence interval (68.04%, 85.16%). Multivariate analysis revealed that increased age, bedridden condition, presence of cerebrovascular diseases at diagnosis, pre-existing cardiopathy and low serum albumin level were associated with the elevated 1-year mortality rate of BP.

Keywords: bullous pemphigoid; cerebrovascular disease; corticosteroid; mortality; prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use*
  • Cerebrovascular Disorders / complications
  • China
  • Diabetes Complications / complications
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Factors / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Length of Stay
  • Male
  • Middle Aged
  • Minocycline / therapeutic use
  • Pemphigoid, Bullous / blood
  • Pemphigoid, Bullous / complications
  • Pemphigoid, Bullous / drug therapy*
  • Prednisone / therapeutic use*
  • Prognosis
  • Psoriasis / complications
  • Retrospective Studies
  • Serum Albumin / metabolism

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Immunosuppressive Agents
  • Serum Albumin
  • Minocycline
  • Prednisone